fosinopril has been researched along with Left Ventricular Hypertrophy in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Tang, J; Wang, L; Wu, C | 1 |
| Fang, C; Huang, ZB; Lin, MH; Wu, W; Yuan, GY; Zhou, SX | 1 |
| Deng, CY; Huang, ZB; Lin, MH; Wu, W; Yuan, GY | 1 |
| Liang, X; Sun, M; Xie, X; Yang, T; Yu, G; Zhao, S | 1 |
| Bartels, T; Dominiak, P; Häuser, W; Raasch, W; Rütten, H; Schwartz, C | 1 |
| Grünfeld, JP; Kessler, M; Thuilliez, C; Zannad, F | 1 |
| Dai, G; Huang, K | 1 |
| Atilgan, D; Bilge, AK; Koylan, N; Meriç, M; Ozben, B; Ozcan, M; Tükek, T | 1 |
| Agabiti-Rosei, E; Böhm, M; Castellano, M; Erdmann, E; Flesch, M; Paul, M | 1 |
| Kirpizidis, HG; Papazachariou, GS | 1 |
| Benedict, CR; Douglas, PS; George, D; Kagaya, Y; Litwin, SE; Lorell, BH; Schoen, FJ; Schunkert, H; Weinberg, EO | 1 |
| Frohlich, ED; Grossman, E; Oren, S | 1 |
| Himeno, H; Hiroto, S; Minamisawa, K; Naruse, M; Shionoiri, H; Takasaki, I; Ueda, S | 1 |
| Deedwania, PC | 1 |
| Cheung, BM; Lau, CP | 1 |
| Frank, H; Globits, S; Hoffmann, U; Kostner, K; Loewe, C; Stefenelli, T | 1 |
| Huang, J; Xiang, Y | 1 |
| Atamas, N; Dong, Y; Liao, WC; Shaffer, E; Wei, C; Zhou, H | 1 |
| Liang, X; Su, M; Xie, X; Yu, G; Zhao, S | 1 |
2 review(s) available for fosinopril and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Fosinopril. Clinical pharmacokinetics and clinical potential.
Topics: Absorption; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Interactions; Female; Fosinopril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Liver; Liver Diseases; Male; Myocardial Ischemia; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 1997 |
The progression from hypertension to heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Disease Progression; Female; Fosinopril; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Middle Aged | 1997 |
5 trial(s) available for fosinopril and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristics.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Fosinopril; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2002 |
Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild-to-moderate essential hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Electrocardiography; Female; Fosinopril; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged | 2005 |
Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients: a double-blind study.
Topics: Blood Pressure; Blood Pressure Determination; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nifedipine | 1995 |
Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Weight; Double-Blind Method; Echocardiography; Electrocardiography; Electrolytes; Female; Fosinopril; Heart Rate; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Peptidyl-Dipeptidase A; Placebos; Urine | 1999 |
The effects of ACE inhibitor therapy on left ventricular myocardial mass and diastolic filling in previously untreated hypertensive patients: a cine MRI study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiac Volume; Diastole; Female; Follow-Up Studies; Fosinopril; Heart Ventricles; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardium; Prospective Studies; Ventricular Dysfunction, Left | 2001 |
12 other study(ies) available for fosinopril and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Fabry disease with early-onset ventricular dilation: A case report.
Topics: Adolescent; Aftercare; alpha-Galactosidase; Angiotensin-Converting Enzyme Inhibitors; Dilatation, Pathologic; Echocardiography; Electrocardiography; Enzyme Replacement Therapy; Fabry Disease; Fosinopril; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Metoprolol; Mutation; Sympatholytics; Treatment Outcome | 2020 |
Effect of fosinopril on the transient outward potassium current of hypertrophied left ventricular myocardium in the spontaneously hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Fosinopril; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Potassium Channels; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2014 |
Fosinopril improves the electrophysiological characteristics of left ventricular hypertrophic myocardium in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Calcium Channels, L-Type; Electrophysiological Phenomena; Fosinopril; Hypertrophy, Left Ventricular; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium Channels | 2014 |
Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; Fibrosis; Fosinopril; Hypertension; Hypertrophy, Left Ventricular; Losartan; Myocardium; Rats; Rats, Inbred SHR | 2002 |
Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Captopril; Circadian Rhythm; Dose-Response Relationship, Drug; Enalapril; Endothelin-1; Fosinopril; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Inbred SHR | 2002 |
The effect and mechanism of forsinopril on ventricular hypertrophy of SHR and left ventricular pressure overloading rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Female; Fosinopril; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Transforming Growth Factor beta | 2002 |
Dose-dependent dissociation of ACE-inhibitor effects on blood pressure, cardiac hypertrophy, and beta-adrenergic signal transduction.
Topics: Adenylyl Cyclases; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Fosinopril; GTP-Binding Proteins; Hypertrophy, Left Ventricular; Myocardium; Norepinephrine; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta; Signal Transduction | 1995 |
Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Blood Pressure; Cardiac Output, Low; Echocardiography; Fosinopril; Hypertension; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Myocardium; Rats; Rats, Wistar; Survival Analysis; Ventricular Function, Left | 1994 |
Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Enalapril; Female; Fosinopril; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Male; Middle Aged; Ventricular Function, Left | 1996 |
Effect of valsartan and fosinopril on catecholamine-induced cardiac hypertrophy.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Calcium-Transporting ATPases; Collagen; Female; Fosinopril; Hypertrophy, Left Ventricular; Male; Myocardium; Norepinephrine; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Tetrazoles; Valine; Valsartan; Ventricular Remodeling | 2000 |
The cardiovascular actions of omapatrilat in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiovascular Agents; Endocardium; Fosinopril; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Pyridines; Rats; Rats, Inbred SHR; Thiazepines; Ventricular Function, Left | 2001 |
Diverse effects of chronic treatment with losartan, fosinopril, and amlodipine on apoptosis, angiotensin II in the left ventricle of hypertensive rats.
Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; China; Disease Models, Animal; Fosinopril; Heart Ventricles; Hypertrophy, Left Ventricular; Losartan; Models, Cardiovascular; Myocardium; Random Allocation; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1 | 2001 |